Cancer and non-cancer risk analysis of vaping. Part I
May 29, 2026 by substack.com
Cancer and non-cancer risk analysis of vaping. Part I
Risk analysis of nicotine and tobacco products requires a clear distinction between combustible smoke exposure and non-combustible forms of nicotine delivery. Evidence on cancer and non-cancer risks continues to show that the greatest health burden is linked to toxicants produced through combustion, rather than nicotine itself. Researchers argue that comparing products through relative risk, exposure levels and disease pathways is essential for avoiding misleading conclusions in public health communication. The analysis reinforces the importance of evidence-based regulation that recognises meaningful differences between cigarettes, vaping products and other smoke-free nicotine alternatives.
